Journal of Laboratory Medicine and Quality Assurance

Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2288-7261   pISSN 2384-2458

Table. 2.

Table. 2.

Acceptable rates based on urine analyzers of different companies

InstrumentpHProteinGlucoseKetoneBilirubinBloodUrobilinogenNitriteLeukocyteTotal
YD92.797.498.499.599.598.799.699.797.8580 (39.8)
SD95.697.698.799.599.597.398.999.399.0318 (21.8)
Roche81.898.099.999.299.796.695.499.299.4216 (14.8)
DFI91.387.297.199.099.299.499.499.899.2140 (9.6)
Siemens88.797.999.299.493.399.498.899.499.289 (6.1)
Eiken87.393.898.892.393.091.998.199.799.149 (3.4)
Sysmex99.694.510089.098.389.299.199.895.532 (2.2)
Arkray95.199.310099.310083.110099.398.624 (1.6)
Beckman99.093.393.399.083.793.399.099.089.79 (0.6)

Values are presented as % or number (%).

The instruments were from the following companies: YD (YD Diagnostics, Yongin, Korea), SD (Standard Diagnostics, Seoul, Korea), Roche (Roche Diagnostics, Mannheim, Germany), DFI (DFI Co. Ltd., Gimhae, Korea), Siemens (Siemens Healthcare, Erlangen, Germany), Eiken (Eiken Chemical Co., Tokyo, Japan), Symex (Symex Co., Kobe, Japan), Arkray (Arkray Inc., Kyoto, Japan), and Beckman (Beckman Coulter Inc., Brea, CA, USA).

J Lab Med Qual Assur 2019;41:75-81 https://doi.org/10.15263/jlmqa.2019.41.2.75
© 2019 J Lab Med Qual Assur